|
|
| F-50067 / Pierre Fabre (0 Trials) |
|
| F0002-ADC / Shanghai Fudan-Zhangjiang (0 Trials) |
|
| F001 / Eli Lilly (0 Trials) |
|
| F0024 / Shanghai Fudan-Zhangjiang (0 Trials) |
|
| F007 (rituximab biosimilar) / Lunan Pharma (0 Trials) |
|
| F14512 / Pierre Fabre (0 Trials) |
|
| F17464 / Pierre Fabre (0 Trials) |
|
| F182112 / Lunan Pharma (0 Trials) |
|
| F3-8-60 / Qualigen Therap (0 Trials) |
|
| F373280 / Pierre Fabre (0 Trials) |
|
| F527 / Lunan Pharma (0 Trials) |
|
| F573 / Gyre Therapeutics (0 Trials) |
|
| F598 / Alopexx (0 Trials) |
|
| F61 injection / Sinopharm (0 Trials) |
|
| FA-relaxin (BMS-986259) / BMS (0 Trials) |
|
| FAAH inhibitor / Eurofins Advinus (0 Trials) |
|
| FAAH inhibitor / Amgen (0 Trials) |
|
| FAB-111 / Ferrer International (0 Trials) |
|
| Fabagal (fabrazyme biosimilar) / ISU Abxis (1 Trials) |
|
| Fabhalta (iptacopan) / Novartis (0 Trials) |
|
| Fablyn (lasofoxifene) / Sermonix (5 Trials) |
|
| Fabrazyme (agalsidase beta) / Sanofi (4 Trials) |
|
| Fabry Disease Therapeutic / Abeona Therap (0 Trials) |
|
| Faceptor (trastuzumab biosimilar) / Nanogen Biopharma (0 Trials) |
|
| Factocel IX (freeze dried human coagulation factor IX) / Intas (0 Trials) |
|
| Factocel VIII (dried human antiheamophilic factor VIII) / Intas (0 Trials) |
|
| Factor IX (human coagulation factor IX) / Hemobras (0 Trials) |
|
| factor VIIa HEPtune conjugate / Heparinex, Novo Nordisk (0 Trials) |
|
| Factor VIII (human coagulation factor VIII) / Hemobras (0 Trials) |
|
| Factor VIII mimetic / Bicycle Therap (0 Trials) |
|
| factor VIIIa mimetic BsAb therapeutic / Sanofi (0 Trials) |
|
| Factor X P Behring (human coagulation factor IX/human coagulation factor X) / CSL Behring (0 Trials) |
|
| factor Xa variant (CB-FXa) / Catalyst Biosci (0 Trials) |
|
| fadanafil (XZP-5849) / Sihuan Pharmaceutical (0 Trials) |
|
| fadolmidine (MPV-2426) / Recro Pharma, Orion Corp (0 Trials) |
|
| fadraciclib (CYC065) / Cyclacel (4 Trials) |
|
| faecalibacterium prausnitzii EXL01-strain (EXL01) / Exeliom Biosciences (0 Trials) |
|
| FAK-JAK 2 dual Inhib / Teva (0 Trials) |
|
| Fakhra Vaccine / Organization of Defensive Innovation and Research (0 Trials) |
|
| falbikitug (AZD0171) / AstraZeneca (0 Trials) |
|
| faldaprevir (BI201335) / Boehringer Ingelheim (0 Trials) |
|
| Falkieri (esketamine inhalation) / Celon Pharma (0 Trials) |
|
| famciclovir / Generic mfg. (3 Trials) |
|
| famitinib (SHR 1020) / Jiangsu Hengrui Pharma (47 Trials) |
|
| famotidine / Generic mfg. (27 Trials) |
|
| famotidine/ibuprofen / Generic mfg. (0 Trials) |
|
| FANA antisense oligonucleotide therapeutic / AUM LifeTech (0 Trials) |
|
| Fanapt LAI (iloperidone depot injectable formulation) / Vanda (1 Trials) |
|
| Fanhdi (human plasma derived coagulation factor VIII) / Grifols (1 Trials) |
|
| fanregratinib (HMPL-453) / Hutchmed (3 Trials) |
|
| Fantom (sirolimus-eluting bioresorbable scaffold) / REVA Medical (4 Trials) |
|
| FAP-activated Balixafortide / Avacta (0 Trials) |
|
| FAP-activated Capecitabine / Avacta (0 Trials) |
|
| FAP-activated Gemcitabine / Avacta (0 Trials) |
|
| FAP-activated MK-2206 / Avacta (0 Trials) |
|
| FAP-activated PARP inhibitors / Avacta (0 Trials) |
|
| FAP-activated small molecule PD-1 Inhibitor / Avacta (0 Trials) |
|
| FAP-IL12 / Philogen (0 Trials) |
|
| FAPI-74 / Novartis (0 Trials) |
|
| FAPXIL (encapsulated IL-10) / Therapyx (0 Trials) |
|
| farletuzumab (MORAB-003) / Eisai (0 Trials) |
|
| farletuzumab ecteribulin (MORAb-202) / Eisai (1 Trials) |
|
| farudodstat (ASLAN003) / Almirall, ASLAN Pharma (1 Trials) |
|
| Farxiga (dapagliflozin) / Ono Pharma, AstraZeneca (336 Trials) |
|
| Farydak (panobinostat) / Secura Bio (15 Trials) |
|
| Fas-CD40 CAR-T therapy / Autolus (0 Trials) |
|
| FAS031 / FASgen (0 Trials) |
|
| FAS093 / FASgen (0 Trials) |
|
| FAS247 / FASgen (0 Trials) |
|
| fasedienol (PH94B NS) / VistaGen (0 Trials) |
|
| Fasenra (benralizumab) / AstraZeneca (37 Trials) |
|
| fasiglifam (TAK-875) / Takeda (0 Trials) |
|
| fasinumab (REGN475) / Teva, Mitsubishi Tanabe, Regeneron (0 Trials) |
|
| fasitibant (MEN 16132) / Menarini (0 Trials) |
|
| FASN / Sareum (0 Trials) |
|
| fasoracetam (NB-001) / Nobias Therap (1 Trials) |
|
| fasudil / Generic mfg. (0 Trials) |
|
| FATE-NK100 / Fate Therap (1 Trials) |
|
| favezelimab (MK-4280) / Merck (MSD) (6 Trials) |
|
| favezelimab/pembrolizumab (MK-4280A) / Merck (MSD) (0 Trials) |
|
| favipiravir / Generic mfg. (35 Trials) |
|
| fazirsiran (TAK-999) / Arrowhead, Takeda (1 Trials) |
|
| fazpilodemab (BFKB8488A) / Roche (0 Trials) |
|
| FB-101 / 1ST Bio, D&D Pharmatech (0 Trials) |
|
| FB-631 / Folia Biotech (0 Trials) |
|
| FB121 (ibalizumab biosimilar) / Microbio (0 Trials) |
|
| FB3001 / Frontier Biotech (0 Trials) |
|
| FB317 (omalizumab biosimilar) / Microbio (0 Trials) |
|
| FB418 / 1ST Bio (0 Trials) |
|
| FB704A / Microbio (1 Trials) |
|
| FB825 / LEO Pharma (2 Trials) |
|
| FB849 / 1ST Bio (0 Trials) |
|
| FBM5712 topical / Thirona Bio, EnZen Therap (0 Trials) |
|
| FBR-002 / Fab’entech (0 Trials) |
|
| Fc-MDNA413 / Medicenna (0 Trials) |
|
| FCARH143 / BMS, Fred Hutchinson Cancer Center, National Cancer Institute (0 Trials) |
|
| FCN-098 / Fosun Pharma (0 Trials) |
|
| FCN-207 / Fosun Pharma (0 Trials) |
|
| FCN-338 / Fosun Pharma (0 Trials) |
|
| FCN-411 / Fosun Pharma (0 Trials) |
|
| FCR001 / Tourmaline Bio (0 Trials) |
|
| FCX-013 / Paragon Biosci (1 Trials) |
|
| FDA022-BB05 / Shanghai Fudan-Zhangjiang (0 Trials) |
|
| FDL169 / Flatley Discovery Lab (2 Trials) |
|
| FDL169 back-up / Flatley Discovery Lab (0 Trials) |
|
| FDL176 / Flatley Discovery Lab (1 Trials) |
|
| FDL176 back-up / Flatley Discovery Lab (0 Trials) |
|
| FE 999310 / Ferring (0 Trials) |
|
| febuxostat / Generic mfg. (72 Trials) |
|
| Fegrast (filgrastim biosimilar) / Claris (0 Trials) |
|
| Feiba (anti-inhibitor coagulant complex) / Takeda (5 Trials) |
|
| feladilimab (GSK3359609) / GSK (7 Trials) |
|
| felbamate / Generic mfg. (1 Trials) |
|
| felbinac trometamol / Shijiazhuang Yiling Pharma (0 Trials) |
|
| felcisetrag (TAK-954) / Theravance Biopharma (0 Trials) |
|
| Felexin (cefalexin monohydrate) / Remedica (0 Trials) |
|
| felezonexor (CBS9106) / Menarini (0 Trials) |
|
| felmetatug vedotin (PF-08046048) / Pfizer (0 Trials) |
|
| Felocard (felodipine) / Orient Europharma (0 Trials) |
|
| felzartamab (MOR202) / Biogen (4 Trials) |
|
| Femathina (MPI-674) / AstraZeneca, Meditrina (0 Trials) |
|
| Femitra (acolbifene/GnRH agonist/prasterone) / Endoceutics (0 Trials) |
|
| Femivia (prasterone (DHEA)/acolbifene) / Endoceutics (0 Trials) |
|
| Femring (estradiol acetate, Estrace VR, Menoring, estradiol acetate IVR, estradiol acetate intravaginal ring) / AbbVie (0 Trials) |
|
| Femseven (estradiol transdermal) / Theramex, EMD Serono (2 Trials) |
|
| Femtrace (estradiol acetate) / AbbVie (0 Trials) |
|
| fencamfamine prodrug (PRX-P4-003) / Praxis Bioresearch (0 Trials) |
|
| Fendrix (hepatitis B (rDNA) vaccine adjuvanted, adsorbed) / GSK (0 Trials) |
|
| fenebrutinib (RG7845) / Roche (4 Trials) |
|
| fenobam (AT002) / Autism Therap (0 Trials) |
|
| Fenocid (fenofibric acid) / Hanmi (0 Trials) |
|
| fenofibrate / Generic mfg. (42 Trials) |
|
| fenofibrate nanoparticle formulation / Generic mfg. (9 Trials) |
|
| fenofibrate/pravastatin / Generic mfg. (0 Trials) |
|
| fenofibric acid / Generic mfg. (2 Trials) |
|
| fenoldopam / Generic mfg. (3 Trials) |
|
| fenoterol / Generic mfg. (3 Trials) |
|
| fenretinide (RT-101) / reVision Therap (0 Trials) |
|
| fenretinide nanoparticle (ST-001 nanoFenretinide) / SciTech Development (0 Trials) |
|
| fenretinide oral (LAU-7b) / Laurent Pharma (1 Trials) |
|
| Fenrock (fentanyl transdermal) / Cassava (0 Trials) |
|
| fentanyl (AT 3022) / Nitto Denko (0 Trials) |
|
| fentanyl (JNS020QD) / J&J (0 Trials) |
|
| fentanyl buccal / Generic mfg. (4 Trials) |
|
| fentanyl citrate / Generic mfg. (6 Trials) |
|
| Fentanyl Ethypharm (fentanyl citrate) / Ethypharm, Grunenthal (0 Trials) |
|
| fentanyl oral spray / Generex (0 Trials) |
|
| fentanyl patch (MRQ 01) / Maruishi Pharma (0 Trials) |
|
| Fentanyl Taifun (fentanyl) / J&J (3 Trials) |
|
| fentanyl transdermal patch / Generic mfg. (0 Trials) |
|
| fepixnebart (LY3016859) / Eli Lilly (1 Trials) |
|
| Feraccru (ferric maltol) / Shield Therap (0 Trials) |
|
| Feraheme (ferumoxytol injection) / Azurity Pharma (7 Trials) |
|
| Ferium XT-DHA (ferrous ascorbate, folic acid and dHA) / Emcure (0 Trials) |
|
| Feron (interferon-beta-1b) / Daiichi Sankyo, Toray (0 Trials) |
|
| Feronsure (interferon alpha-2a biosimilar) / Nanogen Biopharma (0 Trials) |
|
| Ferriprox CR (deferiprone controlled-release) / Apotex (1 Trials) |
|
| ferritin nanocage‐based peptide delivery system / Korea Institute of Science and Technology (0 Trials) |
|
| ferritin nanoparticles based coronavirus vaccine / Stanford University (0 Trials) |
|
| Ferro-Folgamma (iron sulfate siccatum + folic acid + cyancobalamine) / Wörwag (0 Trials) |
|
| ferroptosis inhibitors / Collaborative Medicinal Development (0 Trials) |
|
| ferroquine (SSR97193) / Sanofi (1 Trials) |
|
| ferroquine/artefenomel / Evotec, Sanofi, Medicines for Malaria Venture (0 Trials) |
|
| ferrous fumarate / Remedica (0 Trials) |
|
| fesomersen (IONIS-FXI-LRx) / Ionis (0 Trials) |
|
| fesoterodine / Generic mfg. (0 Trials) |
|
| Fetal NPC / CHA Bio & Diostech (0 Trials) |
|
| Fetroja (cefiderocol) / Shionogi (7 Trials) |
|
| Fetzima (levomilnacipran ER) / Pierre Fabre, AbbVie (2 Trials) |
|
| fevipiprant (QAW039) / Novartis (0 Trials) |
|
| fexagratinib (ABSK091) / Abbisko (8 Trials) |
|
| Fexinidazole Winthrop (fexinidazole) / Sanofi (0 Trials) |
|
| fexofenadine / Generic mfg. (19 Trials) |
|
| Fexuclue (fexuprazan) / Daewoong Pharma (0 Trials) |
|
| fezagepras (PBI-4050) / Liminal BioSci (0 Trials) |
|
| fezakinumab (ILV-094) / Pfizer (0 Trials) |
|
| FF-10101 / Fujifilm Holdings (1 Trials) |
|
| FF-1027T IV / Fujifilm Holdings (0 Trials) |
|
| FF-1027T oral / Fujifilm Holdings (0 Trials) |
|
| FF-10501-01 / Fujifilm Holdings, Strategia Therap (0 Trials) |
|
| FF-10502 / Fujifilm Holdings (0 Trials) |
|
| FF21101 / Strategia Therap, Fujifilm Holdings (1 Trials) |
|
| FFP-102 / AbbVie (0 Trials) |
|
| FFP104 / FF Pharma (2 Trials) |
|
| FG-3165 / FibroGen (0 Trials) |
|
| FG-3246 / Fortis Therap, FibroGen (0 Trials) |
|
| FG-4539 / FibroGen (0 Trials) |
|
| FG-M108 / FutureGen Biopharmaceutical (0 Trials) |
|
| FG-M131 / FutureGen Biopharmaceutical (0 Trials) |
|
| FGFR2/3/4 inhibitor / Applied Pharmaceutical Sci (0 Trials) |
|
| FGFR3 (ACH) / Tyra Biosci (0 Trials) |
|
| FGM-Factor (filgrastim biosimilar) / AC Farma (0 Trials) |
|
| FGX15-147-based ADC / Femtogenix, University of Southampton (0 Trials) |
|
| FH-2001 / Fosun Pharma (0 Trials) |
|
| FH-MagIC TCR-T / Fred Hutchinson Cancer Center, SignalOne Bio (0 Trials) |
|
| FH-TCR-Tᴍsʟɴ / Fred Hutchinson Cancer Center (0 Trials) |
|
| fhB7H3.CAR-Ts / IIT MediTech, Xuzhou Medical University (0 Trials) |
|
| FHCT001 / FullHope Biomedical (0 Trials) |
|
| FHD-286 / Foghorn Therap (0 Trials) |
|
| FHD-609 / Foghorn Therap (0 Trials) |
|
|